Targeting PI3K/Akt signal transduction for cancer therapy

The phosphatidylinositol 3-kinase (PI3K)/Akt pathway plays a crucial role in various cellular processes and is aberrantly activated in cancers, contributing to the occurrence and progression of tumors. In this review, we discuss the roles of the PI3K/Akt pathway in various cancer phenotypes, review the current statuses of different PI3K/Akt inhibitors, and introduce combination therapies consisting of signaling inhibitors and conventional cancer therapies.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Examining the upstream and downstream nodes of this pathway could allow full elucidation of its function.
• 2 Based on accumulating evidence, strategies targeting major components of the pathway might provide new insights for cancer drug discovery.
• 3 Researchers have explored the use of some inhibitors targeting this pathway to block survival pathways.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: